Last activity: 18.08.2022
Categories: Artificial IntelligenceBioTechDataDrugHumanLabLifeTechnologyUniversity
NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.
Website visits
2.5K /mo.
Location: United States, California, San Mateo
Employees: 1-10
Phone: (650) 918-6363
Total raised: $3.5M
Founded date: 2008

Investors 2

Funding Rounds 1

26.06.2013Series A$3.5M-

Mentions in press and media 24

18.08.2022Искусственный интеллект в медицине: сферы, технологии и перспективыИскусственный интеллект, внедряемый в узкоспециальных областях, оказывается перспективнее более общих проектов, недостатки которых мы рассмотрели в предыдущей статье на примере беспилотных автомобилей. На этот раз разберем медицинские техно...
26.03.2018This is how AI will shape drug discoveryAn oft-quoted statistic is that it takes 12 years and almost $2 billion dollars to bring an average drug to market. That is the raison d’être for the biotech VC industry, which saw $10 billion of capital invested in startups in 2017 alone, ...
09.01.2018Andy Slavitt: When it comes to AI, it is the best of times, worst of times story“To some extent, [AI] is a best of times, worst of times story.” He noted that medtech advancements could lead to people using 3D bioprinting to get a new liver or use predictive analytics to figure out what is the right topic to focus on w...
14.02.2017The opportunities and challenges of AI in health careWe are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! When we asked dozens of venture capitalists where...
19.09.2015Bursting The Top Three Myths To Get Your Healthcare Startup FundedMichael Jin Contributor Michael Jin is a founding partner at TEEC Angel Fund. The evolution of the healthcare industry has brought forth innovative startup opportunities in the past few years. A few are actually helping to change the world....
04.11.2013Big data, turbo-charged. Thompson Reuters & NuMedii partner to find new uses for old drugsSo far, three papers have been published showing the promise of the technology’s matchmaking abilities. In September, Stanford University researchers said a class of antidepressants showed activity in experimental models of small-cell lung ...
02.08.2013For your daily fix of inspiration and insight, follow these 10 physician innovators on TwitterSome of the best healthcare startup stories begin with a doctor. Frustrated by an inefficient procedure or lack of a good tool, he devises a solution to bring to the masses. If it seems like you’ve heard this story more and more recently, i...
27.06.2013Stanford startup NuMedii raises $3.5M in Series A to grow big data for pharma platform“NuMedii’s drug development approach is extremely capital efficient and is designed to be much more successful in bringing new therapeutics to patients. We are excited to have the backing of investors and advisors who have a track record of...
26.06.2013NuMedii Receives $3.5M in Series A FundingNuMedii, Inc., a Menlo Park, CA-based drug discovery company, received $3.5m in Series A funding. The round was led by Claremont Creek Ventures and Lightspeed Venture Partners, with participation from Life Science Angels and others. In conj...
26.06.2013NuMedii Receives $3.5M in Series A PALO ALTO, CA, Firm that discovers and de-risks effective new drugs by translating its predictive Big Data technology, announced that it has received $3.5M in a Series A funding led by Claremont Creek Ventures and Lightspeed Venture Partn...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In